会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
    • 环戊基[b] [1,4]二氮杂[6,7,1-hi]吲哚及其衍生物
    • US06777407B2
    • 2004-08-17
    • US10016331
    • 2001-11-02
    • Annmarie Louise SabbRobert Lewis VogelJames Albert NelsonSharon Joy Rosenzweig-LipsonGregory Scott WelmakerJoan Eileen Sabalski
    • Annmarie Louise SabbRobert Lewis VogelJames Albert NelsonSharon Joy Rosenzweig-LipsonGregory Scott WelmakerJoan Eileen Sabalski
    • A61K3155
    • C07D209/94A61K31/55C07D487/06
    • This invention provides compounds of the formulae: wherein: R1 is hydrogen, —C(O)CH3 or alkyl of 1-6 carbon atoms; R2 and R3 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, cycloalkyl, alkoxy of 1-6 carbon atoms, —CH2OH, fluoroalkyl, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, aryl, or aroyl; R4 and R5 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, fluoroalkyl, —CN, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, or aroyl; R6 and R7 are each independently hydrogen, C1-C6 alkyl or cycloalkyl; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions containing these compounds and methods for their use, including treatment of obsessive-compulsive disorder, panic disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.
    • 本发明提供下式的化合物:其中:R 1是氢,-C(O)CH 3或1-6个碳原子的烷基; R 2和R 3各自独立地是氢,1-6个碳原子的烷基,环烷基,烷氧基 1-6个碳原子的-CH 2 OH,氟代烷基,1-6个碳原子的烷基磺酰胺,1-6个碳原子的烷基酰胺,1-6个碳原子的烷基氨基,每个烷基部分1-6个碳原子的二烷基氨基 ,1-6个碳原子的氟烷氧基,2-7个碳原子的酰基,芳基或芳酰基; R4和R5各自独立地是氢,1-6个碳原子的烷基,1-6个碳原子的烷氧基,卤素, 氟烷基,-CN,1-6个碳原子的烷基磺酰胺,1-6个碳原子的烷基酰胺,1-6个碳原子的烷基氨基,每个烷基部分1-6个碳原子的二烷基氨基,1-6个碳的氟烷氧基 原子,2-7个碳原子的酰基或芳酰基; R6和R7各自独立地为氢,C1-C6烷基或环烷基;或其药学上可接受的盐,以及药物组合物conta 包括治疗强迫症,惊恐障碍,抑郁症,焦虑症,广泛性焦虑症,精神分裂症,偏头痛,睡眠障碍,进食障碍,肥胖,癫痫和脊髓损伤的这些化合物和方法。
    • 2. 发明授权
    • [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives
    • [1,4]二氮杂[6,7,1-jk]咔唑及其衍生物
    • US06503900B2
    • 2003-01-07
    • US10017738
    • 2001-11-02
    • Annmarie Louise SabbGregory Scott WelmakerRobert Lewis VogelJoan Eileen Sabalski
    • Annmarie Louise SabbGregory Scott WelmakerRobert Lewis VogelJoan Eileen Sabalski
    • A61K3155
    • C07D487/06
    • This invention provides [1,4]diazepino[6,7,1-jk]carbazole compounds of the formula: wherein: R1 and R2 are H, alkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—SO2-alkyl, —SO2—NH-alkyl, alkyl amide, amino, alkylamino, dialkylamino, fluorinated alkoxy, acyl, phenoyl or thiophenoyl; R3, R4, R5 and R6 are H, alkyl, cycloalkyl, alkoxy or cycloalkoxy; R7 is H or alkyl; R8 is H or alkyl; and the dashed line indicates an optional double bond; or a pharmaceutically acceptable salt thereof, as well as methods and pharmaceutical compositions utilizing them for the treatment or prevention of disorders such as obsessive-compulsive disorder, depression, anxiety, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.
    • 本发明提供下式的[1,4]二氮杂[6,7,1-jk]咔唑化合物:其中:R1和R2是H,烷基,烷氧基,卤素,氟化烷基,-CN,-NH-SO2-烷基 ,-SO 2 -NH-烷基,烷基酰胺,氨基,烷基氨基,二烷基氨基,氟化烷氧基,酰基,苯甲酰基或噻吩甲酰基; R3,R4,R5和R6是H,烷基,环烷基,烷氧基或环烷氧基; R7是H或烷基; R8是H或烷基; 虚线表示可选的双键; 或其药学上可接受的盐,以及利用它们用于治疗或预防诸如强迫症,抑郁症,焦虑症,精神分裂症,偏头痛,睡眠障碍,进食障碍,肥胖,癫痫和脊髓障碍的疾病的方法和药物组合物 线损伤。
    • 6. 发明授权
    • Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
    • 环辛[b] [1,4]二氮杂[6,7,1-hi]吲哚和衍生物
    • US06759405B2
    • 2004-07-06
    • US10016228
    • 2001-11-02
    • Annmarie Louise SabbRobert Lewis Vogel
    • Annmarie Louise SabbRobert Lewis Vogel
    • A61K3155
    • C07D487/06
    • This invention provides compounds of formula I having the structure wherein: R1 and R2 are H, alkyl, cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—SO2-alkyl, —SO2—NH-alkyl, alkyl amide, amino, alkylamino, dialkylamino, fluorinated, acyl, or aroyl; R3, R4 are H, alkyl, cycloalkyl or —CH2-cycloalkyl; R5 is H or alkyl; R6 is H or alkyl; and wherein the dashed line indicates an optional double bond; or a pharmaceutically acceptable salt thereof, as well as methods for using these compounds to treat central nervous system disorders, including obsessive-compulsive disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.
    • 本发明提供具有以下结构的式I化合物,其中R 1和R 2是H,烷基,环烷基,烷氧基,卤素,氟化烷基,-CN,-NH-SO 2 - 烷基,-SO 2 -NH-烷基,烷基酰胺,氨基, 烷基氨基,二烷基氨基,氟化,酰基或芳酰基; R3,R4是H,烷基,环烷基或-CH2-环烷基; R5是H或烷基; R6是H或烷基; 并且其中虚线表示任选的双键; 或其药学上可接受的盐,以及使用这些化合物治疗中枢神经系统疾病(包括强迫症,抑郁症,焦虑症,广泛性焦虑症,精神分裂症,偏头痛,睡眠障碍,进食障碍,肥胖症,癫痫症, 和脊髓损伤。